发明名称 Humanized antibodies against TL1A
摘要 Disclosed are humanized antibodies that bind specifically to TNF superfamily member 15 (TNFSF15), also known as TL1A. Methods of making and using the anti-TL1A antibodies are also described. The humanized antibodies may be antagonists and may used to treat or diagnose conditions associated with TL1A function.
申请公布号 US9416185(B2) 申请公布日期 2016.08.16
申请号 US201414244603 申请日期 2014.04.03
申请人 TEVA BIOPHARMACEUTICALS USA, INC. 发明人 Smith Rodger;Kanakaraj Palanisamy;Roschke Viktor;Rosen Craig;Cooksey Bridget A.
分类号 A61K39/395;C07K16/28 主分类号 A61K39/395
代理机构 Foley & Lardner LLP 代理人 Foley & Lardner LLP
主权项 1. An isolated polynucleotide encoding an antigen-binding polypeptide that binds to specifically to TL1A, comprising: (a) a humanized heavy chain variable region comprising: (1) a CDR-H1 comprises the amino acid sequence selected from the group consisting of LYGMN (SEQ ID NO:11), NYGMN (SEQ ID NO:12), and TSNMGVV (SEQ ID NO:7);(2) a CDR-H2 comprises the amino acid sequence of (WINTYTGEPTYADDFKG) (SEQ ID NO:13) or HILWDDREYSNPALKS (SEQ ID NO:8); and(3) a CDR-H3 comprises the amino acid sequence selected from the group consisting of DTAMDYAMAY (SEQ ID NO:14), DYGKYGDYYAMDY (SEQ ID NO:15), and MSRNYYGSSYVMDY (SEQ ID NO:9); and/or (b) a humanized light chain variable region comprising: (1) a CDR-L1 comprises the amino acid sequence selected from the group consisting of KSSQNIVHSDGNTYLE (SEQ ID NO:16), RSSQSIVHSNGNTYLD (SEQ ID NO:17) and SASSSVNYMH (SEQ ID NO:35);(2) a CDR-L2 comprises the amino acid sequence of KVSNRFS (SEQ ID NO:18) or STSNLAS (SEQ ID NO:36); and(3) a CDR-L3 comprises the amino acid sequence of FQGSHVPLT (SEQ ID NO:19) or HQWNNYGT (SEQ ID NO:37).
地址 Rockville MD US